General Archive
-
News releasesLifeArc partners with EMBARC to improve healthcare for people living with bronchiectasis
Three-year partnership to improve healthcare for thousands of people across Europe living with bronchiectasis.
-
News releasesLifeArc announces £10m funding call for new chronic respiratory infection therapies
First major funding call announced as part of our £100m Chronic Respiratory Infection Translational Challenge
-
News releases£100m programme to transform care for people living with chronic lung conditions
More than 300,000 people in the UK are living with bronchiectasis and more than 10,000 have been diagnosed with cystic…
-
News releasesLifeArc responds to the Government’s renewed pledge to increase R&D funding
LifeArc CEO Dr Melanie Lee welcomes the Government’s restatement of its commitment to increase R&D funding in today’s Autumn statement:…
-
News releasesLifeArc funds home monitoring trials for people with chronic respiratory conditions
Trials will examine the impact of home monitoring and machine learning decision support algorithms for people with CF and bronchiectasis.
-
News releasesLifeArc Ventures invests in Surgery Hero, world’s first digital coaching clinic for patients
Seed funding will be used to scale the solution through the application of machine learning
-
News releasesCall for Government to place medical research at the heart of economic plans
Ahead of the Autumn Statement, LifeArc and other leading life science organisations have written to the Chancellor calling for the…
-
News releasesLifeArc joins forces with Cystic Fibrosis Trust and Medicines Discovery Catapult to strengthen antimicrobial discovery efforts
Pivotal partnership seeks to transform Cystic Fibrosis research
-
News releasesPromising new antibody treatment for osteoporosis and multiple sclerosis
The new antibody offers hope of an effective new treatment option for millions of people.
-
News releasesHer Majesty Queen Elizabeth II
We at LifeArc are deeply saddened by the passing of Her Majesty Queen Elizabeth II.
-
News releasesLifeArc portfolio company Ducentis BioTherapeutics acquired by Arcutis Biotherapeutics for up to $400 million
First exit for LifeArc Ventures, the largest investor in Ducentis, recognising the transformational potential of its science
-
News releasesLifeArc helps create new MRC spin-out company
The new company aims to re-programme microbes to enable new materials to be produced – such as drugs and biodegradable…